Diagnostics News and Research RSS Feed - Diagnostics News and Research

Axumin approved for use in PET scans in patients with recurrent prostate cancer

Axumin approved for use in PET scans in patients with recurrent prostate cancer

The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment. [More]
Meta-genomics analysis tool Taxonomer can rapidly and accurately detect pathogens

Meta-genomics analysis tool Taxonomer can rapidly and accurately detect pathogens

Scientists at the University of Utah, ARUP Laboratories, and IDbyDNA, Inc., have developed ultra-fast, meta-genomics analysis software called Taxonomer that dramatically improves the accuracy and speed of pathogen detection. [More]
New £95 million investment in pathology services set to bring major benefits to millions of patients

New £95 million investment in pathology services set to bring major benefits to millions of patients

A new £95 million investment in laboratory testing and diagnostic services at Central Manchester University Hospitals NHS Foundation Trust will make a major impact on the wide range of general and specialist services provided to CMFT patients who come from all over the Greater Manchester region and beyond. [More]
RBFOX2 dysregulation may cause heart damage in diabetic patients

RBFOX2 dysregulation may cause heart damage in diabetic patients

Cardiac complications are the number one cause of death among diabetics. Now a team of scientists has uncovered a molecular mechanism involved in a common form of heart damage found in people with diabetes. [More]
New imaging methods could help identify early stages of arthrosis

New imaging methods could help identify early stages of arthrosis

Arthrosis, a degenerative disease that affects the joints, becomes more common as people become older. The disease is becoming increasingly common among older people in Finland as well. Arthrosis is currently the subject of research in a number of projects funded by the Academy of Finland. [More]
Sylvester researchers test new KTE-C19 therapy for patients with aggressive non-Hodgkin's lymphoma

Sylvester researchers test new KTE-C19 therapy for patients with aggressive non-Hodgkin's lymphoma

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are testing a novel cellular immunotherapy approach to treating patients with diffuse large B-cell lymphoma who have failed standard therapy. [More]
Rapid hand-held troponin blood test for heart attack diagnosis launched by Philips

Rapid hand-held troponin blood test for heart attack diagnosis launched by Philips

Chest pain patients presenting at the emergency department are set to benefit from a major development by Royal Philips. The company today announced that it has CE marked its cardiac troponin I (cTnI) blood test on the Minicare I-20 handheld device. Minicare cTnI delivers its lab comparable test results in less than 10 minutes near the patient, reducing the time for the physician to decide on treatment. [More]
Diet-based therapy may improve quality of life in IBS patients

Diet-based therapy may improve quality of life in IBS patients

A change in diet can improve the lives of those diagnosed with a common, but hard-to-treat gut disorder. [More]
Vitamin D and androgen receptor-targeted therapy may help treat TNBC

Vitamin D and androgen receptor-targeted therapy may help treat TNBC

A recent study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine revealed that triple-negative breast cancer (TNBC), which has generally been unresponsive to hormone receptor-targeted treatments, can indeed be treated using vitamin D and androgen receptor-targeted therapy. [More]
Study shows endoscopist knowledge of positive Cologuard result may enhance colonoscopy quality

Study shows endoscopist knowledge of positive Cologuard result may enhance colonoscopy quality

An endoscopist's knowledge of a positive Cologuard test improves colonoscopy performance, according to a poster presentation at last week's Digestive Disease Week conference. [More]
New microfluidic device helps extract rare target cells from background cells

New microfluidic device helps extract rare target cells from background cells

A team of researchers from University of Cincinnati in Cincinnati, OH have developed a novel microfluidic device, which combines the inertial effect of fluid and microscale vortices generated in microchambers, to achieve simultaneous double sorting of rare target cells and removal of background cells. [More]
Phase I study of triple drug combination shows promise in multiple myeloma patients

Phase I study of triple drug combination shows promise in multiple myeloma patients

PharmaMar announces the positive results from a Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma. [More]
Study assesses utility of tumor cfDNA as predictor of therapeutic response to immunotherapy

Study assesses utility of tumor cfDNA as predictor of therapeutic response to immunotherapy

Chronix Biomedical, Inc., a developer of blood-based molecular diagnostics, today announces positive data from a blinded proof of concept clinical study, assessing the utility of tumor cell-free DNA as a predictor of therapeutic response to immunotherapy after the first cycle of treatment in eight different types of cancer. [More]
Combining 2-DG with fenofibrate could provide non-toxic treatments for many cancers

Combining 2-DG with fenofibrate could provide non-toxic treatments for many cancers

A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers. [More]
MSF responds to Lord O'Neill's recommendations on how to defeat drug resistance and superbugs

MSF responds to Lord O'Neill's recommendations on how to defeat drug resistance and superbugs

The O'Neill report confirms what MSF has long voiced. The pharmaceutical industry’s system for researching and developing medicines is not always delivering the drugs, vaccines and diagnostics needed. When they are developed, they are often unaffordable or not suitable for the people who need them most [More]
ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

ProBioGen, a leading specialist for contract development and manufacturing of complex glycoproteins and corresponding technologies, today announced that Thermo Fisher Scientific has licensed its GlymaxX® technology for use in development of allergy diagnostics. [More]
Research shows close similarities of canine models of human rare disorders

Research shows close similarities of canine models of human rare disorders

Professor Hannes Lohi's research group at the University of Helsinki has discovered three novel canine genes for Caffey, Raine and van den Ende-Gupta syndromes. Research reveals close similarities of the canine models of human rare disorders and highlights the potential of comparative research approach for the development of rare disease diagnostics and treatments. [More]
Biovica acquires cSens AB - creating opportunities for solving cancer diagnostic challenges

Biovica acquires cSens AB - creating opportunities for solving cancer diagnostic challenges

Biovica has acquired cSens AB, a company that has developed a PCR-based platform for the analysis of serum thymidine kinase (TK) enzyme activity, which correspond to tumor proliferation and cancer aggressiveness. [More]
Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology

Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology

Ipsen S.A., a global specialty-driven pharmaceutical company, and the Institute of Molecular and Cell Biology (IMCB), a research institute under the aegis of the Agency for Science, Technology and Research (A*STAR), Singapore, today announced the signature of a research partnership to study the intracellular trafficking of botulinum neurotoxins (BoNTs) within neurons. [More]
New optimised PCR tests for reliable diagnosis of Zika virus

New optimised PCR tests for reliable diagnosis of Zika virus

DZIF scientists from the University of Bonn have shown that not all conventional Zika virus molecular diagnostic tests for are sufficiently reliable. They developed optimised assays and a control for quantifying viruses in blood and urine. [More]
Advertisement
Advertisement